129 related articles for article (PubMed ID: 37694091)
1. Assessment of Serum Fucose Level among Oral Squamous Cell Carcinoma Patients: A Case-Control Study.
Ashem A; Mehta DN; Singh DN; Singh KC; Anupriya C; Devi AN
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S878-S880. PubMed ID: 37694091
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum levo-fucose levels as a biomarker with tumor node metastasis staging in oral cancer patients.
Manchil PR; Joy ET; Kiran MS; Sherubin JE; Khan MF; Aravind BS
J Pharm Bioallied Sci; 2016 Oct; 8(Suppl 1):S147-S150. PubMed ID: 27829767
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
Parwani RN; Parwani SR
J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
[TBL] [Abstract][Full Text] [Related]
5. Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients.
Vaddamanu SK; Saini RS; Veerabasavaiah BT; Alhamoudi FH; Ali F Alshadidi A; Lo Giudice A; Cicciù M; Minervini G
Heliyon; 2024 Jan; 10(2):e24211. PubMed ID: 38312635
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum sialic acid, fucose levels and their ratio in oral squamous cell carcinoma.
Chinnannavar SN; Ashok L; Vidya KC; Setty SM; Narasimha GE; Garg R
J Int Soc Prev Community Dent; 2015; 5(6):446-50. PubMed ID: 26759796
[TBL] [Abstract][Full Text] [Related]
7. Assessment of serum L-fucose in brain tumor cases.
Manjula S; Monteiro F; Rao Aroor A; Rao S; Annaswamy R; Rao A
Ann Indian Acad Neurol; 2010 Jan; 13(1):33-6. PubMed ID: 20436744
[TBL] [Abstract][Full Text] [Related]
8. Significance of Serum L-fucose Glycoprotein as Cancer Biomarker in Head and Neck Malignancies without Distant Metastasis.
Shetty RK; Bhandary SK; Kali A
J Clin Diagn Res; 2013 Dec; 7(12):2818-20. PubMed ID: 24551646
[TBL] [Abstract][Full Text] [Related]
9. Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.
Nair KK; Pramod GV; Chaudhuri K; Ashok L
J Clin Diagn Res; 2017 Jul; 11(7):ZC59-ZC62. PubMed ID: 28893045
[TBL] [Abstract][Full Text] [Related]
10. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
11. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
[TBL] [Abstract][Full Text] [Related]
12. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
13. Serum C-reactive protein in oral submucous fibrosis and oral squamous cell carcinoma: A cross-sectional study.
Gosavi SR; Torkadi AA
J Oral Maxillofac Pathol; 2020; 24(1):46-51. PubMed ID: 32508447
[TBL] [Abstract][Full Text] [Related]
14. Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients.
Anitha G; Kumar KV; Deshpande G; Nagaraj M; Kalyani V
J Oral Maxillofac Pathol; 2022; 26(2):218-227. PubMed ID: 35968187
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum Levels of Matrix MetalloProteinase-9 (MMP-9) in Oral Squamous Cell Carcinoma and Its Clinicopathological Correlation.
Benitha G; Ramani P; Jayaraman S; R A; Ramalingam K; Krishnan M
Cureus; 2023 Feb; 15(2):e34954. PubMed ID: 36938194
[TBL] [Abstract][Full Text] [Related]
16. Fucose: A biomarker in grading of oral cancer.
Kumar S; Saxena M; Srinivas K; Singh VK
Natl J Maxillofac Surg; 2015; 6(2):176-9. PubMed ID: 27390492
[TBL] [Abstract][Full Text] [Related]
17. Estimation of serum sialic acid in oral submucous fibrosis and oral squamous cell carcinoma.
Chittemsetti S; Manchikatla PK; Guttikonda V
J Oral Maxillofac Pathol; 2019; 23(1):156. PubMed ID: 31110436
[TBL] [Abstract][Full Text] [Related]
18. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
19. Serum fucose level in oral cancer, leukoplakia, and oral sub mucous fibrosis: A biochemical study.
Kumar S; Suhag A; Kolay SK; Kumar P; Narwal A; Srinivas K; Haideri S
J Family Med Prim Care; 2019 Jul; 8(7):2414-2419. PubMed ID: 31463268
[TBL] [Abstract][Full Text] [Related]
20. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
